Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

绝经后的骨质疏松症 绝经后的骨质疏松症

W H Utian

    Lancet (London, England)
    |November 17, 1979
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

    Climacteric : the journal of the International Menopause Society·2022
    Same author

    Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

    Climacteric : the journal of the International Menopause Society·2017
    Same author

    Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.

    Climacteric : the journal of the International Menopause Society·2013
    Same author

    A decade post WHI, menopausal hormone therapy comes full circle--need for independent commission.

    Climacteric : the journal of the International Menopause Society·2012
    Same author

    Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass.

    The Journal of clinical endocrinology and metabolism·2009
    Same author

    The International Menopause Society menopause-related terminology definitions.

    Climacteric : the journal of the International Menopause Society·2002
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章